Will the Cabinet Secretary outline what considerations are given to screening patients who are at a higher risk of contracting neuroendocrine tumours, such as relatives of sufferers or patients who suffer from rare family syndromes such as multiple endocrine neoplasia or Von Hippel-Lindau syndrome, because in all of those there's been a very clear genetic link established? I just wonder if they need to have automatic screening rather than waiting until they have actually got the disease.